winter / spring 2018
January 12, 2018
Theodorus van der Kwast , M.D., Ph.D., FRCPC
Professor and Consultant, Urogenital Pathology, University of Toronto
Director of Research, Laboratory Medicine Program, Princess Margaret Cancer Center, University Health Network (UHN)
Guest of the 2018 Institut du Cancer de Montréal Scientific Day
January 26, 2018
Mark Freedman, M.D.
Senior Scientist, Neuroscience Program, Ottawa Hospital Research Institute
Professor Medicine, Neurology of University of Ottawa
Director, Multiple Sclerosis Research Unit, Neurology, Ottawa Hospital-General Campus
The role of Bone Marrow Transplantation in treating aggressive MS
February 2, 2018 - 11:45 a.m.
Susan Bonner-Weir, Ph.D.
Senior Investigator, Joslin Diabetes Center and Professor of Medicine, Harvard Medical School, MA
Gest of the 2018 Scientific Day of the CRDM
The changing beta cell
February 23, 2018
Janice Robertson, Ph.D.
Tanz Centre for Research in Neurodegenerative Disease, University of Toronto
Amyotrophic Lateral Sclerosis and Frontotemporal Dementia: A Disease Spectrum
March 2, 2018
Christopher E. Rudd, Ph.D.
Chercheur, Centre de recherche, Hôpital Maisonneuve Rosemont
Professeur titulaire, Université de Montréal
Novel T-cell signalling and cellular pathways in immunotherapy
March 23, 2018
Scott C. Baraban, Ph.D.
Professor in Residence of Neurological Surgery, William K. Bowes Jr. Endowed Chair in Neuroscience Research, University of California, San Francisco
April 6, 2018
Chercheur, maladies infectieuses et immunes
Professeur titulaire, département de biochimie, microbiologie et bio-informatique, Faculté des sciences et de génie, Université Laval
Titulaire de la Chaire de recherche du Canada sur les bactériophages
CRISPR-Cas9 systems: from humble beginnings to today's headlines
April. 13, 2018
Professor Jean-Marc Cavaillon, Dr.Sc.
Directeur de recherche, Département Infection et épidémiologie, Institut Pasteur, Paris, France
Leukocyte reprogramming after severe inflammation
April 20, 2018
Michael Karin, Distinguished Professor, Ph.D.
UC San Diego School of Medicine, Department of Pharmacology, California
Metabolic and Immune Control of Liver Tumorigenesis
April 27, 2018
Luis Brubo Barreiro, Ph.D.
Chercheur, maladies virales, immunitaires et cancers, Centre de recherche, CHU Sainte-Justine
Professeur adjoint, Département de pédiatrie, Université de Montréal
May 4, 2018
Senior Scientist, RI-MUHC, Glen site, Cancer Research Program
Professor, Department of Medicine, Division of Medical Genetics, Fellow of the Canadian Academy of Health Sciences, McGill University
May 11, 2018
Elisa E. Konofagou, Ph.D.
Professor of Biomedical Engineering
Professor of Radiology, Department of Biomedical Engineering, Columbia University
Brain drug delivery and neuromodulation using ultrasound
May 25, 2018
Ossama Al-Mefty, M.D.
Professor of Neurological Surgery, Harvard medical School, MA
Dans le cadre du Symposium de la division de neurochirurgie de l’Université de Montréal
June 8, 2018
Marco Marra, Ph. D., FRS(C), FCAHS
Director and Distinguished Scientist, Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency
Professor and Head, Department of Medical Genetics, Faculty of Medicine, University of British Columbia
Canada Research Chair in Genome Science, University of British Columbia
September 1, 2017
Silke Grabherr, M.D.
Director, University Center of Legal Medicine, Lausanne - Geneva
Professor, Faculty of Biology and Medicine, Lausanne, Faculty of Medicine and Faculty of Law of the University of Geneva
Multi-phase Post-mortem angiography: an effective method of minimally invasive autopsy
September 8 , 2017
Director, Life Sciences and Foreign Investment Division, Quebec Ministry of Economy, Science and Innovation
Presentation of a new Québec Life Sciences Strategy
September 22, 2017
Arash Grakoui, Ph.D.
Associate Professor, Emory Vaccine Center, Department of Medicine, Division of Infectious Diseases
Researcher, Yerkes National Primate Research Center, Emory University School of Medicine
Host-driven alterations in gut microbiota and intrahepatic immune pathology
September 29, 2017
Guillaume Ferreira, Ph.D.
Research director, National Institute of Agricultural Research, Université de Bordeaux
Neurocognitive impact of early-onset obesity: evidence from animal models
October 6, 2017
Aaron D. Gitler, Ph.D.
Professor of Genetics, University of Stanford, California
Simple model systems provide insight into mechanisms of human neurodegenerative diseases
October 13, 2017
Daniel Drucker, M.D., FRCPC
Senior Investigator, Lunenfeld-Tanenbaum, Research Institute, Mount Sinai Hospital
Reproducible translational research - A highway paved with potholes and pitfalls
October 20, 2017
Laurent Chatel-Chaix, Ph.D.
Assistant professor, Institut National de la Recherche Scientifique (INRS), Institut Armand-Frappier, Laval
Morphological and Functional Remodeling of the Cytoplasm by Flaviviruses
November 3, 2017
Jean-Frédéric Colombel. M.D.
Professor of Medicine, Director of the Suzan and Leonard Feinstein Inflammatory Bowel Disease Center and the Leona M and Harry B.Helmsley Charitable, Trust Inflammatory Bowel Disease Center, Mount-Sinai Hospital, New York
New therapeutic strategies in inflammatory bowel diseases (IBD)
November 10, 2017
Michel Bouvier, PH.D., FCAHS, FRSC
Chief Executive Officer, IRIC
Principal Investigator, Molecular Pharmacology research unit, IRIC
Professor, Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Université de Montréal
Deputy Vice-Rector Research, Discovery, Creation and Innovation
The molecular and structural basis of GPRC signaling selectivity and spatio-temporal propagation
November 17, 2017
Richard A. Koup, M.D.
Chief, Immunology Laboratory
Deputy Director, Vaccine Research Center, NIAID, NIH
Immunopathogenesis of HIV/SIV infection in lymph nodes
November, 27, 2017
Bernard Courtieu, Ph. D., M.B.A.
Chairman and Chief Executive Officer, IntegraGen
From research to routine clinical practice: Bio-informatic tools are permitting the use of large scale sequencing
December 1, 2017
Jon McGavock, Ph. D.
Associate Professor, Department of Pediatrics, Faculty of Health Sciences, University of Manitoba
Research scientific, Children’s Hospital Research Institute of Manitoba (CHRIM), Winnipeg, MB
Pediatric Type 2 Diabetes in Canada - DREAMing of ways to Curb the Crisis
December 8, 2017
Lisa McKerracher, Ph. D.
Founder and Chief Executive Officer, BioAxone, BioSciences, Cambridge, MA
Developing a new drug for orphan CNS disorders: the path from benchside to clinic
December 15, 2017
John Rioux, Ph. D.
Professor of medicine, University of Montreal and Montreal Heart Institute
CRC in Genetics and Genomic Medicine
Can genetics and genomics truly contribute to drug target identification and precision medicine?
Robert Bowser, Ph. D.
Professor of Neurology and Neurobiology
Director, Gregory W. Fulton ALS Research Center, Barrow Neurological Institute and St. Joseph’s Hospital and Medical Center, Phoenix, AZ USA
Discovery and validation of ALS biomarkers: Insights into disease mechanisms and clinical utility
Jean DaSilva, Ph. D.
Professor, Department of Radiology, Radiation Oncology and Nuclear Medicine and Department of Pharmacology and Physiology, Université de Montréal
Scientific Manager, Radiochemistry and Cyclotron Core Facility and PET Imaging;
Development of new tracers for the PET imaging of angiotensin II AT1 receptors
Scott M. Sternson, Ph. D.
Group Leader, Howard Hughes Medical Institute, Janelia Research Campus, Ashburn, Virginia
The Systems and Molecular Neuroscience of Hunger
Mark T. Nelson, Ph. D.
Distinguished Professor and Chair, Department of Pharmacology, University of Vermont
Robert Larner MD College of Medicine
Capillaries as decoders of the neural rhythm of the brain: Translating thought into blood flow
Laura Solt, Ph. D.
Assistant Professor, Department of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida
Nuclear receptors and the regulation of TH17-mediated inflammation
Jacques Côté, Ph. D.
Canada Research Chair in Chromatin Biology and Molecular Epigenetics
Professor, Department of Molecular Biology, Medical Biochemistry and Pathology, Université Laval Associate Director, Oncology Research Theme at the CHU de Québec-Université Laval Research Center
Role of tumor suppressor acetyltransferases complexes in genome expression and maintenance
Don W. Cleveland
Director, Laboratory of Cell Biology, Department of Cellular and Molecular Medicine, Ludwig Institute for Cancer Research
Distinguished Professor and Chair, Department of Cellular and Molecular Medicine, University of California, San Diego
Gene silencing therapy for neurodegenerative disease
Jeffrey S. Mogil, Ph. D.
E. P. Taylor Professor of Pain Studies, Canada Research Chair in the Genetics of Pain
Director, Alan Edwards Centre for Research on Pain , McGill University
Pain in Mice and Man: Ironic Adventures in Translation
Marie-Josée Hébert, M.D., FRCPC
Vice-Rector of Research, Discovery, Creation and Innovation
Professor, Faculty of Medicine, Université de Montréal
Opportunities and challenges of research at the frontiers of health data science
Adriana Di Polo, Ph. D.
Professor, Department of Neuroscience, Université de Montréal
Researcher, Neuroscience Research Theme, CRCHUM
The molecular basis of neuronal dysfunction in glaucoma: new insights
Matthieu Schmittbuhl, DMD, M. Sc., Ph. D.
Professor, Faculty of Dentistry, Université de Montréal
Head of the Department of Dental Medicine, CHUM
Researcher, Imaging and Engineering Research Theme, CRCHUM
New prospects for CBCT imaging
Thomas J. Hope, Ph. D.
Professor, Departments of Cell and Molecular Biology, Obstetrics and Gynecology, Northwestern University
Co-PI, The Sustained Long-Acting Protection Against HIV (SLAP HIV) Program; Director, Viral Pathogenesis Core, Third Coast Center for AIDS Research
Visualizing HIV Sexual Transmission and Prevention Utilizing NHP Models
Jef D. Boeke, Ph. D.
Director, Institute for Systems Genetics
Professor, Department of Biochemistry and Molecular Pharmacology, NYU School of Medicine
Building synthetic chromosomes from scratch
Paul Wheatley-Price, MBChB, MRCP (UK)
Department of Medicine, Division of Medical Oncology, Ottawa Hospital Cancer Centre
Update in lung Cancer treatment: Immuno-Oncology and target therapies
Monsef Benkirane, Ph. D.
Research Director, CNRS, Full Professor, director of the Molecular Virology team
Director of the Institute of Human Genetics
Finding, understanding and eliminating the HIV reservoir
Hertzel C. Gerstein, M.D., M. Sc., FRCPC
Professor, Department of Medicine, McMaster University, Hamilton, Ontario
Population Health Institute Chair in Diabetes Research
Is “Real World” Evidence a Reliable Way to Identify Effective Therapies?
Lora Hooper, Ph. D.
Professor of Immunology
Director, Bader Center for Research on Arthritis and Immune Diseases
Chairman, Department of Immunology, University of Texas Southwestern Medical Center
The gut microbiome: a master regulator of metabolism
Charles M. Rice, Ph. D.
Maurice R. and Corinne P. Greenberg Professor in Virology, The Rockefeller University
Scientific and Executive Director, Center for the Study of Hepatitis C, New York
Recipient of the 2016 Lasker Award
Honorary Researcher, CHUM Research Centre
Unraveling Nature's Intrinsic and Innate Antiviral Defenses
Alain Moreau, Ph. D.
Researcher, CHU Sainte-Justine
Full Professor, Department of Biochemistry, Faculty of Medicine, Université de Montréal
Full Professor, Faculty of Dentistry, Université de Montréal
Recent advances in understanding the role of Pitx1 transcription factor in normal bone development and disease
Nicolas Chomont, Ph. D.
Associate Professor and Researcher, Department of Microbiology, Infectiology and Immunology, Université de Montréal
HIV reservoirs: Where, When and How does HIV hide?
Kenneth Kosik, M.D.
Professor of Neuroscience, University of California, Santa Barbara
Early Decisions in Neural Fate Determination
Amit Bar-Or, M.D., FRCPC
Neurologist, Neuroimmunologist and Professor in the Department of Neurology and Neurosurgery at the Montreal Neurological Institute and Hospital (the Neuro), McGill University
B cell: Myeloid: T cell interactions and treatment of CNS inflammatory disease
Manon Choinière, Ph. D.
Full Professor, Department of Anesthesiology, Université de Montréal
Making innovative clinical research in the field of chronic pain a priority
Gilles Soulez, M.D., M. Sc.
Full Professor and Director, Department of Radiology, Radiation Oncology and Nuclear Medicine, Université de Montréal
Image-based modelling of abdominal aortic aneurysms
Daniel Douek, M.D., Ph. D.
Senior Investigator and Chief, Human Immunology Section at the Vaccine Research Center of the NIAID, NIH
Mechanisms of virus persistence in HIV controllers
Erwan Bezard, Ph. D.
Research Director at the CNRS; Université de Bordeaux, Researcher and Lab Director, Institute of Neurodegenerative Diseases
Animal models of synucleopathies
David Labbé, Eng., Ph. D.
Professor, Software and IT Engineering Department, École de Technologie Supérieure
Researcher, CRCHUM, Imaging and Engineering Research Theme
Associate Professor, School of Optometry, Université de Montréal
Virtual reality to prevent sports injuries and improve motor rehabilitation
Walther Mothes, Ph. D.
Professor of Microbial Pathogenesis, Yale University School of Medicine, Connecticut
Seeing Is Believing – Visualizing individual steps of the retroviral life cycle in living animals and at the single molecule level
Louis Bherer, Ph. D.
Full Professor, Department of Medicine, Université de Montréal
Researcher, Montreal Heart Institute
Benefits of cognitive training and physical exercise in older adults
Robert Weinberg, Ph. D.
Director of the Ludwig Center for Molecular Oncology, Massachusetts Institute of Technology (MIT)
Mechanisms of malignant progression
Marylise Duperthuy, Ph. D.
Assistant Professor, Department Microbiology, Infectious Diseases and Immunology, Université de Montréal
Modulation of pathogenic Vibrio membrane vesicles by antimicrobial peptides
Yves Joanette, Ph. D., FCAHS
Scientific Director, Institute of Aging of the CIHR
Professor, Faculty of Medicine, Université de Montréal
Chair, World Dementia Council
Aging, health and well-being – Current and future programs
*These conferences are accredited by the Royal College of Physicians and Surgeons of Canada as continuing professional development activities.
The CRCHUM conferences are made possible thanks to the financial support of our partners: